Nevus Sebaceus

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-05-28
Clinical Trial Update: 12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi [Phase 2]
A Phase 2 trial evaluating NFX-179 Gel for epidermal nevus and nevus sebaceus has been withdrawn.